Facebook
Twitter
Telegram
Report an ErrorNGM Biopharmaceuticals Cash Flow 2011-2024 | NGM
Annual Cash Flow NGM Biopharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-132 M | -144 M | -73.2 M | -83.5 M | -41.2 M | -7.6 M | -17.4 M | - | - | - | - | - | - |
Depreciation & Amortization |
2.22 M | 4.04 M | 6.09 M | 6.56 M | 7.6 M | 7.22 M | 6.44 M | - | - | - | - | - | - |
Accounts Payables |
2.98 M | 8.45 M | 5.25 M | 9.66 M | 9.03 M | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow NGM Biopharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -41.8 M | - | -114 M | - | -35.7 M | - | -54.9 M | - | -22.2 M | - | -63.5 M | -38.3 M | -19.1 M | - | -26.6 M | -19.9 M | -12.1 M | - | -14.6 M | -8.75 M | -4.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
500 K | 600 K | 609 K | - | 600 K | 1.4 M | 1.43 M | - | 1.5 M | 1.6 M | 1.55 M | - | 1.6 M | 1.7 M | 1.73 M | - | 1.9 M | 1.9 M | 1.96 M | - | 1.9 M | 1.7 M | 1.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
4.69 M | 5.86 M | 13.3 M | 8.45 M | 3.56 M | - | 4.82 M | 5.25 M | 7.63 M | 5.14 M | 7.54 M | 9.66 M | 9.66 M | 9.66 M | 9.66 M | 9.03 M | 9.03 M | 9.03 M | 9.03 M | 5.78 M | 5.78 M | 5.78 M | 5.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency